Back

Prevalence and prognostic implication of left ventricular hypertrophy defined by different echocardiographic criteria

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment Epidemiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Anping Cai

Guangdong Provincial People's Hospital, Guangzhou (China)

3 More presentations in this session

Presentation thumbnail
Identification of premature cardiovascular disease using a family-based strategy: a feasibility pilot study
Mr P. Charleux (Paris, FR)
Abstract Slides Video
Presentation thumbnail
False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study
Doctor E. Kaplan (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Predictors of cardiovascular disease risk: findings from the National Survey of Health and Development Cohort.
Doctor E. Agwara (Cambridge, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Cardiac magnetic resonance (CMR) height-based allometric scaling in Southeast Asians; implications in the diagnosis and prognosis of left ventricular hypertrophy (LVH): the REMODEL study
thumbnail
Congress Presentation
Left ventricular hypertrophy, wall thickness, and histological myocyte alteration in end-stage heart failure: a call for a standard definition
thumbnail
Congress Presentation
Diagnostic and prognostic value of ECG-predicted hypertension mediated left ventricular hypertrophy using machine learning

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources